James Arthur Bristol, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 46,548 shares at $43.93 ($2.0M) on 2020-04-09, disclosed to the SEC on 2020-04-13.
Open-market sale of $2.0M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.97 | 6,373 | $274K | 13.4% |
| 2 | $42.97 | 6,373 | $274K | 13.4% |
| 3 | $43.93 | 5,621 | $247K | 12.1% |
| 4 | $43.93 | 5,621 | $247K | 12.1% |
| 5 | $44.18 | 11,012 | $487K | 23.9% |
| 6 | $44.18 | 11,012 |
| $487K |
| 23.9% |
| 7 | $45.88 | 536 | $25K | 1.2% |
| Total | $43.81 avg | 46,548 | $2.0M | 100% |
| Filing → |
| DCPH | SELL | 2021-04-14 | $1.3M | — | Filing → |
| DCPH | SELL | 2021-01-20 | $352K | — | Filing → |
| DCPH | SELL | 2020-10-13 | $2.5M | — | Filing → |